This is a type of eye inflammation (uveitis) that can happen in one eye after a serious injury to the other eye. The injured eye causes the inflammation in the second eye. It's a reaction to the initial injury.
Every report comes from a Lived member, sent anonymously.
Have you tried Prednisone for Sympathetic Ophthalmia?
Sympathetic ophthalmia is a rare inflammation inside both eyes that can develop after one eye has a penetrating injury or eye surgery. The injured or operated eye is called the inciting eye. The other eye, which was never harmed, is called the sympathizing eye, because it becomes inflamed in response to what happened to its partner. The condition is a form of uveitis, inflammation of the uvea, the pigmented middle layer of the eye that includes the iris and the choroid (the layer of blood vessels beneath the retina). In sympathetic ophthalmia the inflammation usually involves the whole uvea in both eyes. An early symptom is often blurred near vision or difficulty focusing up close, followed by pain, redness, sensitivity to light, floaters and worsening vision. Without treatment it can cause serious vision loss in both eyes, which is why it matters even though it is uncommon. Most cases begin within months of the injury or surgery: in one large review, about 80% started within 3 months and 90% within a year. It can also appear within days, or many years later, and cases have been reported decades afterward.
Sympathetic ophthalmia is thought to be an autoimmune reaction. Tissue inside the eye is normally hidden from the immune system. When an injury or operation exposes that tissue, the immune system can meet it for the first time, treat it as foreign and then attack the same tissue in both eyes. Researchers do not yet know why this happens in a few people and not in most. The two main triggers are penetrating eye injuries (also called open-globe injuries, in which the wall of the eye is cut or ruptured) and surgery inside the eye. Reported operations include retina surgery such as vitrectomy, glaucoma surgery, cataract surgery and procedures that treat glaucoma by destroying part of the eye's fluid-producing tissue. Repeated operations on the same eye and a delay in repairing a penetrating injury appear to raise the risk. The risk after any single event is low. Pooled studies estimate that it follows about 2 in every 1,000 open-globe injuries and about 6 in every 10,000 eye surgeries. Injury-related cases are more common in children and young adults, while surgery-related cases are more common in older adults, who have more eye operations.
No single test confirms sympathetic ophthalmia. An eye specialist, often one experienced in uveitis, makes the diagnosis from the pattern of inflammation in both eyes together with a history of injury or surgery to one eye. That history is central, so it helps to mention any past eye injury or operation, even one from many years ago. The examination includes a slit lamp (a microscope for the front of the eye) and a dilated view of the retina. Imaging supports what the exam suggests and later shows how well treatment is working. Optical coherence tomography (OCT), a quick scan using light, shows fluid under the retina and swelling. Fluorescein angiography, a series of photographs taken after dye is injected into a vein, shows spots where the back of the eye is leaking. Ultrasound can image the eye when inflammation or a cataract blocks the view. Before starting treatment that suppresses the immune system, doctors look for infection, because conditions such as tuberculosis can cause similar inflammation, and steroids or immune-suppressing medicines can make an untreated infection worse. Sarcoidosis, an inflammatory disease, is also considered. The closest look-alike is Vogt-Koyanagi-Harada disease, an autoimmune condition that inflames both eyes in a very similar way but occurs without any eye injury or surgery. Diagnosis is harder when both eyes have had operations, because it is then less clear which eye set off the reaction.
Treatment aims to calm the inflammation quickly and then keep it from returning, because each flare can damage the retina and other parts of the eye. Care is usually led by an ophthalmologist with uveitis experience, sometimes alongside a rheumatologist or another specialist who manages immune-suppressing medicines. The first step is high-dose corticosteroids, anti-inflammatory steroid medicines taken by mouth (such as prednisone or prednisolone) or, in severe cases, given through a vein for a few days as methylprednisolone. The inflammation usually responds quickly, and the dose is then lowered gradually over two to three months. High-dose steroids, especially when given through a vein, can push up blood pressure and blood sugar and can reactivate dormant tuberculosis, so they are monitored closely. Because the disease tends to flare as steroids are reduced, most people also start a steroid-sparing immunosuppressant at the outset, since these medicines take weeks to take effect. Common choices include mycophenolate mofetil, azathioprine, methotrexate and cyclosporine. They allow lower steroid doses but need regular blood tests to watch for effects on blood counts, the liver or the kidneys. Some of them, including mycophenolate and methotrexate, can cause miscarriage or birth defects, so anyone who could become pregnant or is planning a pregnancy should discuss this before starting. When inflammation persists despite them, a biologic medicine that blocks a specific inflammatory signal may be added, such as adalimumab (Humira), which is approved for noninfectious uveitis affecting the middle, back or whole of the eye. Experience with biologics in sympathetic ophthalmia itself comes mainly from small case reports. All of these treatments raise the risk of infection, and people are screened for tuberculosis before starting a biologic. Steroid injections or slow-release steroid implants placed inside the eye can add local control, particularly for swelling of the macula (the center of the retina), but they raise the risk of cataract and glaucoma. Removing the injured eye is sometimes discussed after a severe injury. When an eye cannot be repaired and has no chance of useful sight, surgeons may remove it early, ideally within about two weeks, partly to lower this risk. Removing an eye that can be repaired, purely as prevention, is generally not favored: studies have not shown that it lowers the risk compared with repair, and the injured eye can turn out to be the one with better vision.
Sympathetic ophthalmia is usually a long-term condition rather than a single episode. Many people need immune-suppressing treatment for an extended period, and the plan is adjusted step by step while the inflammation stays quiet. Relapses are common, especially as medicines are reduced, so eye visits are frequent at first and spaced out once things are stable. Daily medicines and regular appointments become part of ordinary routines, and during a flare, blurred or reduced vision can make reading, driving or work harder for a while. With prompt, sustained treatment, the outlook is much better than it once was. In one review of treated patients, about 70% had improved vision in the sympathizing eye, and more than half of those reached 20/40 or better (seeing at 20 feet what a person with typical vision sees at 40 feet). Some people still lose significant vision, particularly when diagnosis is delayed or inflammation keeps returning. Complications can come from the disease or from its treatment. Cataract and glaucoma (raised pressure inside the eye that can damage the optic nerve) are common; both are treatable but need monitoring. Cataract surgery is usually planned only after the inflammation has been quiet for at least three months. Regular blood tests and checks for medicine side effects are part of long-term care.
Anyone who has had a penetrating eye injury or eye surgery should contact an eye doctor promptly if the other eye develops blurred near vision or trouble focusing up close, pain, redness, sensitivity to light, new floaters or declining vision. Mention the earlier injury or operation, even if it was years ago, because early treatment can change the course of the disease. If you are already being treated, contact your eye care team promptly if symptoms return or worsen as medicines are lowered, or if you develop a fever or other signs of infection while taking immune-suppressing medicines.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Sympathetic Ophthalmia is like, what's helped you, or ask the community a question.